Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial. - Wikidata - awgldk - TriplyDB

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.

http://www.wikidata.org/entity/Q44473761

about

Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS The role of lopinavir/ritonavir (Kaletra) in the management of HIV infected adults.Long-term treatment of patients with HIV-1: the role of atazanavir Initial therapy for human immunodeficiency virus: broadening the options.Actual medication pill burden and dosing frequency in HIV-infected patients with undetectable viral loads.Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.Atazanavir for the treatment of human immunodeficiency virus infection.Atazanavir: the advent of a new generation of more convenient protease inhibitors.Review of atazanavir: a novel HIV protease inhibitor.Strategies for management and treatment of dyslipidemia in HIV/AIDS.Antiretroviral treatment regimen outcomes among HIV-infected prisoners.Atazanavir: simplicity and convenience in different scenarios.Role of atazanavir in the treatment of HIV infection HIV protease inhibitors: recent clinical trials and recommendations on use.Differences in implementation of HIV/AIDS clinical research in developed versus developing world: an evidence-based review on protease inhibitor use among women and minorities.Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir.Predictors of virological response to atazanavir in protease inhibitor-experienced patients.[Metabolic alterations in HIV-associated lipodystrophy syndrome].Raltegravir with unboosted atazanavir 300 mg twice daily in antiretroviral treatment-experienced participants.Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients.Rash in an HIV-positive patient.A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients

P2860

Q24792952-C01E2BB0-3257-4C6A-9450-1FCADD78614D Q30343901-F23AD421-E9D2-4831-9AF2-AA8B47924EA5 Q35557219-85B1C8DB-F173-4C3E-9787-569D7699D3A0 Q35759609-B5007233-57DD-4643-884C-DFF03A7C0643 Q35878022-A3D4EAC3-DA88-48CF-920D-E402DC352221 Q35968731-CEED1575-F89A-48E0-A702-086473FA0061 Q35976835-3F7D8B81-12F2-4ECB-8DB4-84A2CF467EE2 Q36070100-E3A25BA5-7C2F-4A24-AB53-E12F56487E76 Q36222006-30A26A0A-E606-496C-B243-AFE762DCC29B Q36336563-189FC5BC-FE01-4ADE-92AA-50433B8B8432 Q36692794-6F8DE50C-68E8-4F37-8681-C0DD5A9E690C Q36765802-FE0AC99B-1797-4D0D-8960-7DED046250CD Q37230298-2B20B0B0-3D64-43F4-8D3C-A8D8A99F0543 Q37519715-3DF70EAF-0E8C-4A3A-823D-811FD66830AD Q38069146-464EF19B-032F-409F-9420-EAF057D50EA9 Q40903070-EC5A6148-78A3-4664-9464-3E2E767DFA7D Q43244207-09AEBC8E-0B8F-458D-A58E-6AAA985B7A2E Q45096975-21E8A816-BF29-4F57-BCB2-D7113BF54BBF Q45099760-40A3DAD1-062F-407E-9964-2E04BA4CAA3D Q46095764-B364B963-23FD-49DC-8415-4D1B97635EE6 Q46127996-5DB35F7A-C03F-4991-B536-B47CDBA56152 Q46789876-0DFA7F4B-7774-420A-B2A8-209F55CF5DC4 Q57425194-0CC231F1-94C9-448A-9541-F63BAC8EBD52

P2860

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.

http://www.wikidata.org/entity/Q44473761

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@en

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@nl

type

label

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@en

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@nl

prefLabel

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@en

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@nl

P1433

Q44473761-955EC2C8-409B-4C23-8E61-222E0E12ACE2

P1476

Q44473761-03384BEC-0560-41D0-850E-522B4816885E

P2093

Q44473761-2379596C-EDC5-4707-B2D9-62EBFAD4571A

Q44473761-2CE35137-CDD7-41C8-8021-C3234AE7F723

Q44473761-4419332F-2FAA-40AF-BFAE-5A1FDF38ECFB

Q44473761-503AAFE7-CF7A-4099-9D0D-AA8463CDB1F2

Q44473761-89BE41AD-BC88-46B1-A73D-D068F70E1556

Q44473761-8F16ADB6-9217-4B2A-8623-E34820621B4A

Q44473761-A1567E09-BA1C-4CC8-9ACA-F1FBE5EE7B9C

Q44473761-B991AEE6-49FC-476D-A3A6-0A13D1DFC589

Q44473761-E7599122-5B43-4B41-9DED-C23915624A8B

Q44473761-FED969D5-1850-4959-B1BC-A50C41B90B02

P304

Q44473761-F9B6B3D3-885F-4F04-832D-BB3003BAC1C3

P31

Q44473761-C7ED7570-6330-4359-AED5-48FD6D4B014C

P356

Q44473761-7783E19A-990D-41CA-ACBD-8D38625D0425

P407

Q44473761-56DDE097-F9DE-48F5-9E1A-4C7BA039D744

P433

Q44473761-4CBEE1C3-1404-4A1D-88CB-8968877A23E6

P478

Q44473761-6072DEAE-4C71-4E9D-9DC6-9C860AF44AA6

P577

Q44473761-B276A740-D047-448F-B521-C3F78839B9B9

P698

Q44473761-F1EFB5C2-D010-4A7F-B751-4123D7DC7EAF

P921

Q44473761-9EC8387E-5173-4F6F-A7F8-B1AE361CCEE7

Q44473761-B2F8D718-9A09-4B6B-BA82-E79E263B69F7

P356

00002030-200306130-00008

P1433

P1476

Therapy with atazanavir plus s ...... mized comparative pilot trial.

@en

P2093

Alexandra Thiry

http://www.w3.org/2001/XMLSchema#string

Carlos Zala

http://www.w3.org/2001/XMLSchema#string

Danilo Nunes

http://www.w3.org/2001/XMLSchema#string

David W Haas

http://www.w3.org/2001/XMLSchema#string

Hans Jaeger

http://www.w3.org/2001/XMLSchema#string

Michael Sension

http://www.w3.org/2001/XMLSchema#string

Peter Piliero

http://www.w3.org/2001/XMLSchema#string

Protocol AI424-009 Study Group

http://www.w3.org/2001/XMLSchema#string

Shannon Schrader

http://www.w3.org/2001/XMLSchema#string

Steven Schnittman

http://www.w3.org/2001/XMLSchema#string

P304

1339-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00002030-200306130-00008

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12799555

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug